Google Chrome
Safari
Firefox
Edge
Search
Press Release / Mar 10, 2016
Hovione and Vertex Partner in Continuous Manufacturing
Hovione today announced that it plans to host and operate a commercial-scale continuous manufacturing facility as part of an agreement with Vertex Pharmaceuticals
Press Release / Sep 20, 2019
Hovione announces successful end-of-phase 2 meeting with the FDA and outlines phase 3 program for minocycline topical gel
Hovione announced details of its planned MARS-2 and MARS-3 (Minocycline Against Rosacea Study) Phase 3 development program for the treatment of moderate to severe inflammatory rosacea.
News / Sep 17, 2021
World Patient Safety Day 2021
Safety First, Quality Always: We are continuously improving the safety of our operations with the patient’s safety in mind.
Press Clipping / May 12, 2025
Partnership advances liver cancer treatment
Scientist Live, 12 May 2025
Hovione New Jersey
Manufacturing Plant and R&D Center
Press Release / Aug 01, 2005
Hovione Group sales grow 8% for fiscal year 2004/05
Hovione announces that the consolidated sales volume for the fiscal year ended 31st March 2005 amounted to US$81.4 million, representing a growth of 8% over the previous year.
News / Jun 12, 2020
Hovione receives the NJDEP Environmental Stewardship Award
The New Jersey Department of Environmental Protection awarded Hovione New Jersey with the Environmental Stewardship